Recipharm definition

Recipharm. Recipharm Holdings Limited, a wholly-owned subsidiary of Recipharm AB "Recipharm Group" Recipharm AB and its subsidiary undertakings and where the context permits, each of them "Registrar of Companies" the Registrar of Companies in England and Wales "Regulatory Information Service" a regulatory information service as defined in the FCA Handbook "relevant securities" Consort Shares, other Consort share capital and any securities convertible into or exchangeable for, and rights to subscribe for, any of the foregoing
View Source

Examples of Recipharm in a sentence

  • Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of Recipharm and Consort about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements.

  • The Offer is being made in the United States by Recipharm and no one else.

  • This announcement (including information incorporated by reference in this announcement), oral statements made regarding the Proposed Acquisition, and other information published by Recipharm and Consort contain statements which are, or may be deemed to be, "forward- looking statements".

  • It may be difficult for US holders of Consort securities to enforce their rights and any claim arising out of the US federal securities laws, since Recipharm and Consort are located outside of the United States, and some or all of their officers and directors may be resident outside of the United States.

  • The forward-looking statements contained in this announcement include statements relating to the expected effects of the Proposed Acquisition on Recipharm and Consort (including their future prospects, developments and business strategies), the expected timing and scope of the Proposed Acquisition and other statements other than historical facts.

  • Delivery terms will be EXW Recipharm Monts site (Incoterms 2010).

  • The Recipharm Group estimates that within 18 months after completion, SEK 125 million (approximately £10.1 million) in annual cost synergies will be realised, with the potential for additional cost and revenue synergies in the medium to long term.

  • In order to repay the Bridge Facility and lower net debt, Recipharm AB intends to carry out one or several share issues of approximately SEK 2,500 million in total (the "Share Issues") whereof at least SEK 2,000 million is a rights issue with preferential rights for Recipharm AB's shareholders, subject to approval by a general meeting (the "Rights Issue") and up to SEK 500 million without preferential rights for Recipharm AB's shareholders.

  • The largest shareholders of Recipharm AB, ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ and ▇▇▇▇ Backsell, who together hold approximately 27.1 per cent.

  • Recipharm AB and Recipharm acknowledge and agree that before completion of the Acquisition, the Consort Board (and, where appropriate the Consort Remuneration Committee) may operate the Consort Share Plans as they consider appropriate in accordance with the rules of the relevant Consort Share Plan and Consort's normal practice modified as the Consort Remuneration Committee considers appropriate to take account of any change in legislation.

Related to Recipharm

  • the Licensee means the person(s) named in the licence.

  • VAR means Value at Risk.

  • Licensee has the meaning set forth in the preamble.

  • Siemens means Siemens AG (Germany) and its Affiliates.

  • Licensed User means an employee, contractor or agent of Client who is authorized by Client to access and use the Licensed Software, to whom a password and user ID has been issued by Client and whose access to the Licensed Software has not been terminated, suspended or surrendered.